The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

Vaccinate, inoculate and immunize are three words that describe the "jab" people get to guard them against serious infectious illnesses. Harmonious - yes - but each offers a different consumer expectation.

The three botanicals are synergistically blended with a unique proprietary technology to provide fast relief of acute musculoskeletal pain.